Acumen Pharmaceuticals Inc (ABOS) — Financial Flexibility Index
Acumen Pharmaceuticals Inc (ABOS) has a Financial Flexibility Index of -0.52x as of March 2026. Free cash flow of $-24.13 Million (operating CF $-24.13 Million minus capex $0.00) represents -1% of total liabilities ($46.15 Million). Check Acumen Pharmaceuticals Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Acumen Pharmaceuticals Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Acumen Pharmaceuticals Inc across 7 annual periods. See ABOS current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Acumen Pharmaceuticals Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Acumen Pharmaceuticals Inc. For the full company profile including market capitalisation, see how much is Acumen Pharmaceuticals Inc worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.20x | $-115.45 Million | $-115.54 Million | $52.40 Million | ▼ -46.1% |
| 2024 | -1.51x | $-86.20 Million | $-86.22 Million | $57.18 Million | ▼ -51.1% |
| 2023 | -1.00x | $-43.04 Million | $-43.06 Million | $43.15 Million | ▲ +77.7% |
| 2022 | -4.48x | $-34.99 Million | $-35.15 Million | $7.81 Million | ▼ -28.6% |
| 2021 | -3.48x | $-17.92 Million | $-17.96 Million | $5.15 Million | ▼ -2861.2% |
| 2020 | -0.12x | $-7.41 Million | $-7.45 Million | $63.02 Million | ▲ +67.5% |
| 2019 | -0.36x | $-6.78 Million | $-6.82 Million | $18.74 Million | — |